Australia markets closed

Kiora Pharmaceuticals Inc (7EY0.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.4675-0.0005 (-0.11%)
At close: 04:42PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
12.059
Operating expenses
Research development
4,027
4,027
3,449
5,350
3,566
Selling general and administrative
4,663
4,663
8,278
5,324
4,659
Total operating expenses
8,690
8,690
11,727
10,674
8,225
Operating income or loss
-8,690
-8,690
-11,727
-10,674
-8,213
Interest expense
11.132
11.132
8.599
6.851
4.186
Total other income/expenses net
-3,896
-3,896
-2,018
-3,284
1,344
Income before tax
-12,424
-12,424
-13,697
-13,963
-6,850
Income tax expense
90.319
90.319
-113.01
-192.603
12.055
Income from continuing operations
-12,514
-12,514
-13,584
-13,771
-6,862
Net income
-12,514
-12,514
-13,584
-13,771
-6,862
Net income available to common shareholders
-13,045
-13,045
-13,584
-13,771
-6,862
Basic EPS
0.78
-
-18.55
-57.12
-59.60
Diluted EPS
0.78
-
-18.55
-57.12
-59.60
Basic average shares
3,317
-
732.303
241.099
114.787
Diluted average shares
3,317
-
732.303
241.099
114.787